You are here

  • Home
  • Archive
  • Volume 80, Issue 12
  • Response to: ‘Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus’ by Wang et al

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus’ by Wang et al
Free

Authors

  • Martin Aringer Divsison of Rheumatology, Department of Medicine III, University Medical Center and Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany PubMed articlesGoogle scholar articles
  • Karen Costenbader Division of Rheumatology and Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Thomas Dörner Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany PubMed articlesGoogle scholar articles
  • Sindhu R Johnson Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Martin Aringer, Internal Medicine III, Technical University of Dresden, Dresden 01069, Germany; martin.aringer{at}uniklinikum-dresden.de
View Full Text

Citation

Aringer M, Costenbader K, Dörner T, et al
Response to: ‘Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus’ by Wang et al
Annals of the Rheumatic Diseases 2021;80:e193.

Publication history

  • Received December 10, 2019
  • Accepted December 12, 2019
  • First published December 20, 2019.
Online issue publication 
February 28, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.